FNDC5 and breast cancer: Moreover, data show that the irisin plasma level may be a predictive factor for such conditions as diabetes mellitus 2 [29], cardiometabolic risk in sedentary lifestyles [30], sarcopenia and carotid arteriosclerosis [31], chronic kidney diseases [32], polycystic ovary syndrome [33] or breast cancer [34].